UK Gov Future Fund invests £360k in Nandi Proteins
Reach
AIM: FIPP
16 September 2020
Frontier IP Group plc
("Frontier IP" or the "Group")
Portfolio news - UK Government Future Fund invests £360,000 in Nandi Proteins as part of £720,000 fund raising
Frontier IP, a specialist in commercialising intellectual property, today notes the following announcement from portfolio company Nandi Proteins Limited ("Nandi" or the "Company") that it has raised £720,000 via a convertible loan, including a £360,000 investment from the UK Government's Future Fund.
The investment from the Future Fund, which was established to support innovative businesses through the COVID-19 outbreak, has been matched by £320,000 from the Group and £40,000 invested by Shackleton Finance Limited, which specialises in secondary venture and development capital investments. Frontier IP holds a 20.1 per cent equity stake in the Company. Shackleton is also an existing shareholder.
Nandi is collaborating with a number of industry partners to commercialise its novel process control technology to create ingredients based on animal and vegetable proteins able to replace chemical additives and fat in processed foods. The funding will support the Company in meeting technical and commercial milestones relating to a number of collaborative projects with major industry partners.
Frontier IP chief executive officer Neil Crabb said: "The investment from the Future Fund is an invaluable contribution to supporting Nandi Proteins through the next phase of its development. There is strong interest across the food industry to reduce the levels of additives, fats and meat on both health and environmental grounds. Nandi, with its proven expertise particularly with vegetable proteins, is well placed to benefit from these trends."
Nandi Proteins statement begins:
UK Government Future Fund invests £360,000 in Nandi Proteins as part of £720,000 fund raising
16 September 2020 Nandi Proteins Limited ("Nandi" or the "Company") today announces that it has successfully raised £720,000 via a convertible loan including £360,000 investment from the UK Government's Future Fund, established to support innovative businesses through the COVID-19 outbreak.
The Future Fund's investment has been matched by Frontier IP Group, a specialist in commercialising intellectual property, and Shackleton Finance Limited, a technology-focused venture capital manager. They have invested £320,000 and £40,000 respectively.
The convertible loan will enable Nandi Proteins to meet technical and commercial milestones for its novel process control technology. This is now at an advanced stage of commercialisation through collaborative partnerships with a number of major organisations.
Nandi's technology has a wide range of potential applications. It is based on the knowledge that the functional properties of proteins change as they denature when heat is applied in a very precise way over time. As a result, the technology is able to create new protein-based ingredients to replace chemical additives and fats in processed foods, such as meats, cakes and a host of other products.
Among other projects, Nandi is leading a consortium developing gluten replacements for use in bread. Other members of the consortium include global ingredients business AB Mauri, part of FTSE 100 group AB Foods, and a major UK agronomy firm Agrii, a subsidiary of agri-services group Origin Enterprises. The project is backed by a grant from Coeliac UK and Innovate UK.
The Company is a spin out from Heriot-Watt University, Edinburgh. More information on the principles underpinning Nandi's technology is below.
Nandi Proteins chairman John Price said : "I have been very impressed with the progress at Nandi Proteins since becoming chairman late last year, reflected in the range and strength of the industry collaborations it has been able to forge. We are confident that the Company will see the significant momentum generated to date accelerate as the results of our industry collaborations start to come through."
Nandi Proteins Acting Chief Executive Officer and Frontier IP Chief Commercialisation Officer Matthew White said: "Nandi Proteins is addressing many of the food industry's major concerns including the dangers of obesity, a problem thrown into greater focus by the impact of COVID-19. We are very much looking forward to continuing our work with both existing and new industry partners as they seek to tackle these issues."
Nandi: the technology
Nandi's patented technology is based on the knowledge that the functional properties of proteins change when they unfold (denature). Controlled denaturation can be used to deliberately change and control the protein functionality as an ingredient. The Company is focused on two protein types:
· globular proteins, where the molecules are folded into a spherical shape, found in vegetables and dairy; and
· spiral proteins, where long chains of molecules form spirals or helices. They are found in meat.
In both cases, chemical bonds along the length of, and between different portions of, the protein molecule keep the proteins in their shapes.
Applying heat breaks the weak bonds allowing the proteins to unfold. The structure of the protein that was previously 'inside' the folded protein is now exposed. This allows it to interact with its surroundings -- for example by binding onto water molecules -- enhancing functionality such as solubility and emulsifying ability.
The unfolded structure also allows for new chemical bonds to form between one protein to another. The result is that individual protein molecules can become joined together to create a network which will change functional properties such as thickening and gelation abilities.
These denaturation processes are already widely used in food ingredient processing and cooking. For example, an egg white consists of globular proteins suspended in water. When you fry the egg, the proteins unfold and create a mesh, which traps the water molecules. The egg white solidifies. The challenge is in controlling the process precisely. Cook the egg for too long, too many protein bonds form, the net's mesh becomes too tight, and the white becomes rubbery.
By controlling the heat applied and monitoring the unfolding process extremely precisely, Nandi can precisely create protein functionality that allows it to replace the functionality of fat and additive molecules such as emulsifiers.
Nandi is capable of producing modified proteins from both globular proteins (present in a wide range of naturally-occurring foodstuffs, including whey, potato, soy and peas, as well as eggs) and spiral proteins present in meat (Nandi is specifically exploring the modification of collagen proteins).
Nandi achieves control of the unfolding process by using chemistry and light-based systems to measure in real time a range of key variables as heat is applied to proteins in solution. This allows the Company to maximise their functional properties, such as emulsification, solubility, acid stability, foaming, water binding and gelation.
The company's technology includes proprietary sensor systems which can be used across existing manufacturing processes to control the variables and create functional proteins.
Nandi Proteins statement ends
ENQUIRIES
|
Frontier IP Group plc |
T: 020 7332 2338 |
|
Neil Crabb, Chief Executive Andrew Johnson, Communications & Investor Relations Company website: www.frontierip.co.uk |
neil@frontierip.co.uk M: 07464 546 025 |
|
Allenby Capital Limited (Nominated Adviser) |
T: 0203 328 5656 |
|
Nick Athanas / James Hornigold
|
|
ABout frontier IP
The Group's convertible loan to Nandi Proteins was made by Frontier IP Management Limited, a wholly-owned subsidiary and an Appointed Representative of Privium Fund Management (UK) Limited ("Privium") which is authorised and regulated by the Financial Conduct Authority ("FCA") in the United Kingdom.
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
Latest directors dealings
- 7 hours ago Johnson Matthey
- 9 hours ago Galliford Try
- 9 hours ago Galliford Try
- 9 hours ago Centrica
- 10 hours ago Smith & Nephew